Development and Validation of UPLC-MS/MS Method for Determination of Enasidenib in Rat Plasma and Its Pharmacokinetic Application

Figure 3

Representative chromatograms of enasidenib and IS in rat plasma samples: (a) a blank plasma sample; (b) a blank plasma sample spiked with enasidenib and IS; (c) a rat plasma sample 1.5 h after oral administration of 10 mg/kg enasidenib.

(a)

(b)

(c)